Where will rectal artesunate suppositories save lives?
Journal article
Watson JA. et al, (2024), The Lancet, 403, 1137 - 1138
Response to comment on 'The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis'
Journal article
Watson JA. et al, (2024), eLife, 13
Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysis
Journal article
Commons RJ. et al, (2024), The Lancet Infectious Diseases, 24, 172 - 183
Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis
Journal article
Rajasekhar M. et al, (2024), The Lancet Infectious Diseases, 24, 184 - 195
Primaquine in glucose-6-phosphate dehydrogenase deficiency: an adaptive pharmacometric assessment of ascending dose regimens in healthy volunteers.
Journal article
Pukrittayakamee S. et al, (2024), eLife, 12
Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of phase 2 antiviral studies
Preprint
Wongnak P. et al, (2024)
Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial
Journal article
Luvira V. et al, (2024), BMC Infectious Diseases, 24
Modelling the within-host dynamics ofPlasmodium vivaxhypnozoite activation: an analysis of the SPf66 vaccine trial
Preprint
Mehra S. et al, (2024)
Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial
Journal article
Schilling WHK. et al, (2024), The Lancet Infectious Diseases, 24, 36 - 45
Clinical Antiviral Efficacy of Remdesivir in Coronavirus Disease 2019: An Open-Label, Randomized Controlled Adaptive Platform Trial (PLATCOV)
Journal article
Jittamala P. et al, (2023), The Journal of Infectious Diseases, 228, 1318 - 1325
Rectal artesunate suppositories for the pre-referral treatment of suspected severe malaria.
Journal article
Watson JA. et al, (2023), PLoS Med, 20
Evidence based optimal dosing of intravenous artesunate in children with severe falciparum malaria
Journal article
Haghiri A. et al, (2023), Clinical Pharmacology & Therapeutics
[A global core outcome measurement set for snakebite clinical trials].
Conference paper
Abouyannis M. et al, (2023), Medecine tropicale et sante internationale, 3
Which trial do we need? A global, adaptive, platform trial to reduce death and disability from tuberculous meningitis.
Journal article
Thwaites GE. et al, (2023), Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 29, 826 - 828
Which trial do we need? A global, adaptive, platform trial to reduce death and disability from tuberculous meningitis
Journal article
Thwaites GE. et al, (2023), Clinical Microbiology and Infection, 29, 826 - 828
Lineage-informative microhaplotypes for spatio-temporal surveillance of Plasmodium vivax malaria parasites.
Journal article
Siegel SV. et al, (2023), medRxiv
The CARAMAL study could not assess the effectiveness of rectal artesunate in treating suspected severe malaria.
Journal article
Watson JA. et al, (2023), BMC medicine, 21
Pharmacometric assessment of primaquine induced haemolysis in glucose-6-phosphate dehydrogenase deficiency
Preprint
Pukrittayakamee S. et al, (2023)
Pharmacometrics of high-dose ivermectin in early COVID-19 from an open label, randomized, controlled adaptive platform trial (PLATCOV)
Journal article
Schilling WHK. et al, (2023), eLife, 12